Vascular Solutions Inc. (NASDAQ:VASC) CEO Howard Root sold 40,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $45.11, for a total transaction of $1,804,400.00. Following the completion of the transaction, the chief executive officer now owns 347,840 shares of the company’s stock, valued at $15,691,062.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
A number of equities analysts recently weighed in on the stock. TheStreet upgraded shares of Vascular Solutions from a “hold” rating to a “buy” rating in a report on Monday. Sidoti lowered shares of Vascular Solutions from a “buy” rating to a “neutral” rating and set a $47.00 price objective for the company. in a report on Tuesday, July 12th. Piper Jaffray Cos. boosted their price objective on shares of Vascular Solutions from $45.00 to $49.00 and gave the stock an “overweight” rating in a report on Tuesday. Finally, Zacks Investment Research lowered shares of Vascular Solutions from a “buy” rating to a “hold” rating in a report on Wednesday, June 29th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $44.13.
A hedge fund recently raised its stake in Vascular Solutions stock. Nationwide Fund Advisors raised its position in shares of Vascular Solutions Inc. (NASDAQ:VASC) by 0.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,649 shares of the medical device company’s stock after buying an additional 153 shares during the period. Nationwide Fund Advisors owned 0.18% of Vascular Solutions worth $1,088,000 as of its most recent SEC filing.
Vascular Solutions (NASDAQ:VASC) last issued its earnings results on Monday, July 25th. The medical device company reported $0.33 EPS for the quarter, topping the Zacks’ consensus estimate of $0.30 by $0.03. During the same quarter in the prior year, the company earned $0.29 earnings per share. The company earned $41.20 million during the quarter, compared to the consensus estimate of $41.40 million. Vascular Solutions’s revenue was up 9.7% on a year-over-year basis. On average, equities analysts forecast that Vascular Solutions Inc. will post $1.23 earnings per share for the current year.
Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.
